By expenditures
| Name | Title | Type |
|---|---|---|
| Doana Anderson | DIRECTOR OF BUSINESS AND OPERATIONS | Auditee |
| Timothy Gillette | Partner | Auditee |
| Daniel Miley | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 335353 | 2024 | 2024-12-31 | Talbot Korvola & Warwick LLP | $6.68M |
| 6068 | 2023 | 2023-12-11 | Talbot Korvola & Warwick LLP | $5.21M |
| 53728 | 2022 | 2022-12-12 | Talbot Korvola & Warwick LLP | $4.05M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 335353 | 2024 | 2024-12-31 | 1093827 | 2024-003 | Material Weakness | - | N |
| 335353 | 2024 | 2024-12-31 | 1093826 | 2024-003 | Material Weakness | - | N |
| 335353 | 2024 | 2024-12-31 | 1093825 | 2024-003 | Material Weakness | - | N |
| 335353 | 2024 | 2024-12-31 | 1093824 | 2024-003 | Material Weakness | - | N |
| 335353 | 2024 | 2024-12-31 | 1093823 | 2024-003 | Material Weakness | - | N |
| 335353 | 2024 | 2024-12-31 | 1093822 | 2024-003 | Material Weakness | - | N |
| 335353 | 2024 | 2024-12-31 | 1093821 | 2024-003 | Material Weakness | - | N |
| 335353 | 2024 | 2024-12-31 | 1093820 | 2024-003 | Material Weakness | - | N |
| 335353 | 2024 | 2024-12-31 | 1093819 | 2024-003 | Material Weakness | - | N |
| 335353 | 2024 | 2024-12-31 | 1093818 | 2024-003 | Material Weakness | - | N |
| 335353 | 2024 | 2024-12-31 | 1093817 | 2024-003 | Material Weakness | - | N |
| 335353 | 2024 | 2024-12-31 | 1093816 | 2024-003 | Material Weakness | - | N |
| 335353 | 2024 | 2024-12-31 | 1093815 | 2024-003 | Material Weakness | - | N |
| 335353 | 2024 | 2024-12-31 | 1093814 | 2024-003 | Material Weakness | - | N |
| 335353 | 2024 | 2024-12-31 | 1093813 | 2024-003 | Material Weakness | - | N |
| 335353 | 2024 | 2024-12-31 | 1093812 | 2024-003 | Material Weakness | - | N |
| 335353 | 2024 | 2024-12-31 | 1093811 | 2024-002 | Significant Deficiency | - | I |
| 335353 | 2024 | 2024-12-31 | 1093810 | 2024-002 | Significant Deficiency | - | I |
| 335353 | 2024 | 2024-12-31 | 1093809 | 2024-002 | Significant Deficiency | - | I |
| 335353 | 2024 | 2024-12-31 | 1093808 | 2024-002 | Significant Deficiency | - | I |
| 335353 | 2024 | 2024-12-31 | 1093807 | 2024-002 | Significant Deficiency | - | I |
| 335353 | 2024 | 2024-12-31 | 1093806 | 2024-002 | Significant Deficiency | - | I |
| 335353 | 2024 | 2024-12-31 | 1093805 | 2024-002 | Significant Deficiency | - | I |
| 335353 | 2024 | 2024-12-31 | 1093804 | 2024-002 | Significant Deficiency | - | I |
| 335353 | 2024 | 2024-12-31 | 1093803 | 2024-001 | Significant Deficiency | - | B |
| 335353 | 2024 | 2024-12-31 | 1093802 | 2024-001 | Significant Deficiency | - | B |
| 335353 | 2024 | 2024-12-31 | 1093801 | 2024-001 | Significant Deficiency | - | B |
| 335353 | 2024 | 2024-12-31 | 1093800 | 2024-001 | Significant Deficiency | - | B |
| 335353 | 2024 | 2024-12-31 | 1093799 | 2024-001 | Significant Deficiency | - | B |
| 335353 | 2024 | 2024-12-31 | 1093798 | 2024-001 | Significant Deficiency | - | B |
| 335353 | 2024 | 2024-12-31 | 1093797 | 2024-001 | Significant Deficiency | - | B |
| 335353 | 2024 | 2024-12-31 | 1093796 | 2024-001 | Significant Deficiency | - | B |
| 335353 | 2024 | 2024-12-31 | 517385 | 2024-003 | Material Weakness | - | N |
| 335353 | 2024 | 2024-12-31 | 517384 | 2024-003 | Material Weakness | - | N |
| 335353 | 2024 | 2024-12-31 | 517383 | 2024-003 | Material Weakness | - | N |
| 335353 | 2024 | 2024-12-31 | 517382 | 2024-003 | Material Weakness | - | N |
| 335353 | 2024 | 2024-12-31 | 517381 | 2024-003 | Material Weakness | - | N |
| 335353 | 2024 | 2024-12-31 | 517380 | 2024-003 | Material Weakness | - | N |
| 335353 | 2024 | 2024-12-31 | 517379 | 2024-003 | Material Weakness | - | N |
| 335353 | 2024 | 2024-12-31 | 517378 | 2024-003 | Material Weakness | - | N |
| 335353 | 2024 | 2024-12-31 | 517377 | 2024-003 | Material Weakness | - | N |
| 335353 | 2024 | 2024-12-31 | 517376 | 2024-003 | Material Weakness | - | N |
| 335353 | 2024 | 2024-12-31 | 517375 | 2024-003 | Material Weakness | - | N |
| 335353 | 2024 | 2024-12-31 | 517374 | 2024-003 | Material Weakness | - | N |
| 335353 | 2024 | 2024-12-31 | 517373 | 2024-003 | Material Weakness | - | N |
| 335353 | 2024 | 2024-12-31 | 517372 | 2024-003 | Material Weakness | - | N |
| 335353 | 2024 | 2024-12-31 | 517371 | 2024-003 | Material Weakness | - | N |
| 335353 | 2024 | 2024-12-31 | 517370 | 2024-003 | Material Weakness | - | N |
| 335353 | 2024 | 2024-12-31 | 517369 | 2024-002 | Significant Deficiency | - | I |
| 335353 | 2024 | 2024-12-31 | 517368 | 2024-002 | Significant Deficiency | - | I |
| 335353 | 2024 | 2024-12-31 | 517367 | 2024-002 | Significant Deficiency | - | I |
| 335353 | 2024 | 2024-12-31 | 517366 | 2024-002 | Significant Deficiency | - | I |
| 335353 | 2024 | 2024-12-31 | 517365 | 2024-002 | Significant Deficiency | - | I |
| 335353 | 2024 | 2024-12-31 | 517364 | 2024-002 | Significant Deficiency | - | I |
| 335353 | 2024 | 2024-12-31 | 517363 | 2024-002 | Significant Deficiency | - | I |
| 335353 | 2024 | 2024-12-31 | 517362 | 2024-002 | Significant Deficiency | - | I |
| 335353 | 2024 | 2024-12-31 | 517361 | 2024-001 | Significant Deficiency | - | B |
| 335353 | 2024 | 2024-12-31 | 517360 | 2024-001 | Significant Deficiency | - | B |
| 335353 | 2024 | 2024-12-31 | 517359 | 2024-001 | Significant Deficiency | - | B |
| 335353 | 2024 | 2024-12-31 | 517358 | 2024-001 | Significant Deficiency | - | B |
| 335353 | 2024 | 2024-12-31 | 517357 | 2024-001 | Significant Deficiency | - | B |
| 335353 | 2024 | 2024-12-31 | 517356 | 2024-001 | Significant Deficiency | - | B |
| 335353 | 2024 | 2024-12-31 | 517355 | 2024-001 | Significant Deficiency | - | B |
| 335353 | 2024 | 2024-12-31 | 517354 | 2024-001 | Significant Deficiency | - | B |
| 53728 | 2022 | 2022-12-12 | 627392 | 2022-001 | Significant Deficiency | - | F |
| 53728 | 2022 | 2022-12-12 | 627391 | 2022-001 | Significant Deficiency | - | F |
| 53728 | 2022 | 2022-12-12 | 50950 | 2022-001 | Significant Deficiency | - | F |
| 53728 | 2022 | 2022-12-12 | 50949 | 2022-001 | Significant Deficiency | - | F |